Critical role of peroxisome proliferator activated receptor-δ on body fat reduction in C57BL/6J and human apolipoprotein E2 transgenic mice fed delipidated soybean

Journal of Agricultural and Food Chemistry

Volumn 59, Issue 21, 2011, Pages 11872-11881

  Lee, Ji Hae ^a   Jun, Hee Jin ^a   Jia, Yaoyao ^a   Kim, Wook ^a   Choi, Sung Gil ^b   Lee, Sung Joon ^a  

^a Korea University   (South Korea)

^b Gyeongsang National University   (South Korea)

Author keywords

adiponectin; delipidated soybean; obesity; peroxisome proliferator activated receptor ; uncoupling protein

Indexed keywords

ADIPONECTIN; DELIPIDATED SOYBEAN; OBESITY; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; UNCOUPLING PROTEINS;

CHOLESTEROL; CYTOLOGY; FATTY ACIDS; GENES; GLUCOSE; HORMONES; MUSCLE; NUTRITION; PROTEINS;

MAMMALS;

APOLIPOPROTEIN E2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PLANT MEDICINAL PRODUCT; SOYBEAN PROTEIN;

ADIPOSE TISSUE; ANIMAL; ARTICLE; C57BL MOUSE; CHEMISTRY; DIET THERAPY; DIETARY FIBER; DOWN REGULATION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; MOUSE; OBESITY; SOYBEAN; TRANSGENIC MOUSE;

ADIPOSE TISSUE; ANIMALS; APOLIPOPROTEIN E2; DIETARY FIBER; DOWN-REGULATION; GENE EXPRESSION REGULATION; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OBESITY; PLANT PREPARATIONS; PPAR DELTA; SOYBEAN PROTEINS; SOYBEANS;

GLYCINE MAX; MUS; MUS MUSCULUS;

EID: 80455162681     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf202910u     Document Type: Article

References (60)

1. Kopelman, P. G. Obesity as a medical problem Nature 2000, 404 (6778) 635-643
2. Spiegelman, B. M.; Flier, J. S. Obesity and the regulation of energy balance Cell 2001, 104 (4) 531-543
3. Fontaine, K. R.; Redden, D. T.; Wang, C. X.; Westfall, A. O.; Allison, D. B. Years of life lost due to obesity JAMA, J. Am. Med. Assoc. 2003, 289 (2) 187-193
4. Garcia, M. C.; Torre, M.; Marina, M. L.; Laborda, F. Composition and characterization of soyabean and related products Crit. Rev. Food Sci. Nutr. 1997, 37 (4) 361-391
5. Grieshop, C. M.; Fahey, G. C. Comparison of quality characteristics of soybeans from Brazil, China, and the United States J. Agric. Food Chem. 2001, 49 (5) 2669-2673
6. Grieshop, C. M.; Kadzere, C. T.; Clapper, G. M.; Flickinger, E. A.; Bauer, L. L.; Frazier, R. L.; Fahey, G. C. Chemical and nutritional characteristics of United States soybeans and soybean meals J. Agric. Food Chem. 2003, 51 (26) 7684-7691
7. Velasquez, M. T.; Bhathena, S. J. Role of dietary soy protein in obesity Int. J. Med. Sci. 2007, 4 (2) 72-82
8. Orgaard, A.; Jensen, L. The effects of soy isoflavones on obesity Exp. Biol. Med. (Maywood). 2008, 233 (9) 1066-1080
9. Chen, H. C.; Farese, R. V. Inhibition of triglyceride synthesis as a treatment strategy for obesity-Lessons from DGAT1-deficient mice Arterioscler. Thromb. Vasc. Biol. 2005, 25 (3) 482-486
10. Anderson, J. W.; Johnstone, B. M.; Cook-Newell, M. E. Meta-analysis of the effects of soy protein intake on serum lipids N. Engl. J. Med. 1995, 333 (5) 276-282
11. Ahmadian, M.; Wang, Y.; Sul, H. S. Lipolysis in adipocytes Int. J. Biochem. Cell Biol. 2010, 42 (5) 555-559
12. Blachier, F.; Lancha, A. H.; Boutry, C.; Tome, D. Alimentary proteins, amino acids and cholesterolemia Amino Acids 2010, 38 (1) 15-22
13. Hirche, F.; Schroder, A.; Knoth, B.; Stangl, G. I.; Eder, K. Effect of dietary methionine on plasma and liver cholesterol concentrations in rats and expression of hepatic genes involved in cholesterol metabolism Br. J. Nutr. 2006, 95 (5) 879-888
14. Jobgen, W. S.; Fried, S. K.; Fu, W. J.; Meininger, C. J.; Wu, G. Y. Regulatory role for the arginine-nitric oxide pathway in metabolism of energy substrates J. Nutr. Biochem. 2006, 17 (9) 571-588
15. McKnight, J. R.; Satterfield, M. C.; Jobgen, W. S.; Smith, S. B.; Spencer, T. E.; Meininger, C. J.; McNeal, C. J.; Wu, G. Beneficial effects of L-arginine on reducing obesity: potential mechanisms and important implications for human health Amino Acids 2010, 39 (2) 349-357
16. Fu, W. J. J.; Haynes, T. E.; Kohli, R.; Hu, J. B.; Shi, W. J.; Spencer, T. E.; Carroll, R. J.; Meininger, C. J.; Wu, G. Y. Dietary L-arginine supplementation reduces fat mass in Zucker diabetic fatty rats J. Nutr. 2005, 135 (4) 714-721
17. Iritani, N.; Nagashima, K.; Fukuda, H.; Katsurada, A.; Tanaka, T. Effects of Dietary Proteins on Lipogenic Enzymes in Rat-Liver J. Nutr. 1986, 116 (2) 190-197
18. Kim, S.; Shin, H. J.; Kim, S. Y.; Kim, J. H.; Lee, Y. S.; Kim, D. H.; Lee, M. O. Genistein enhances expression of genes involved in fatty acid catabolism through activation of PPAR alpha Mol. Cell. Endocrinol. 2004, 220 (1-2) 51-58
19. Kersten, S.; Desvergne, B.; Wahli, W. Roles of PPARs in health and disease Nature 2000, 405 (6785) 421-424
20. Kersten, S. Peroxisome proliferator activated receptors and obesity Eur. J. Pharmacol. 2002, 440 (2-3) 223-234
21. Puigserver, P.; Spiegelman, B. M. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): Transcriptional coactivator and metabolic regulator Endocr. Rev. 2003, 24 (1) 78-90
22. Wang, M. H.; Wise, S. C.; Leff, T.; Su, T. Z. Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma Diabetes 1999, 48 (2) 254-260
23. Guay, D. R. Update on fenofibrate Cardiovasc. Drug Rev. 2002, 20 (4) 281-302
24. Wang, Y. X.; Lee, C. H.; Tiep, S.; Yu, R. T.; Ham, J.; Kang, H.; Evans, R. M. Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity Cell 2003, 113 (2) 159-170
25. Anderson, J. W.; Baird, P.; Davis, R. H.; Ferreri, S.; Knudtson, M.; Koraym, A.; Waters, V.; Williams, C. L. Health benefits of dietary fiber Nutr. Rev. 2009, 67 (4) 188-205
26. Sullivan, P. M.; Mezdour, H.; Quarfordt, S. H.; Maeda, N. Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human APOE*2 J. Clin. Invest. 1998, 102 (1) 130-135
27. van Dijk, K. W.; van Vlijmen, B. J.; de Winther, M. P.; van 't Hof, B.; van der Zee, A.; van der Boom, H.; Havekes, L. M.; Hofker, M. H. Hyperlipidemia of ApoE2(Arg(158)-Cys) and ApoE3-Leiden transgenic mice is modulated predominantly by LDL receptor expression Arterioscler. Thromb. Vasc. Biol. 1999, 19 (12) 2945-2951
28. Jeun, J.; Kim, S.; Cho, S. Y.; Jun, H. J.; Park, H. J.; Seo, J. G.; Chung, M. J.; Lee, S. J. Hypocholesterolemic effects of Lactobacillus plantarum KCTC3928 by increased bile acid excretion in C57BL/6 mice Nutrition 2010, 26 (3) 321-330
29. Chung, M. J.; Cho, S. Y.; Bhuiyan, M. J. H.; Kim, K. H.; Lee, S. J. Anti-diabetic effects of lemon balm (Melissa officinalis) essential oil on glucose- and lipid-regulating enzymes in type 2 diabetic mice Br. J. Nutr. 2010, 104 (2) 180-188
30. Nagaoka, S.; Awano, T.; Nagata, N.; Masaoka, M.; Hori, G.; Hashimoto, K. Serum cholesterol reduction and cholesterol absorption inhibition in CaCo-2 cells by a soyprotein peptic hydrolyzate Biosci., Biotechnol., Biochem. 1997, 61 (2) 354-356
31. Iritani, N.; Sugimoto, T.; Fukuda, H.; Komiya, M.; Ikeda, H. Dietary soybean protein increases insulin receptor gene expression in Wistar fatty rats when dietary polyunsaturated fatty acid level is low J. Nutr. 1997, 127 (6) 1077-1083
32. Torres, N.; Torre-Villalvazo, I.; Tovar, A. R. Regulation of lipid metabolism by diseases mediated soy protein and its implication in by lipid disorders J. Nutr. Biochem. 2006, 17 (6) 365-373
33. Nagasawa, A.; Fukui, K.; Funahashi, T.; Maeda, N.; Shimomura, I.; Kihara, S.; Waki, M.; Takamatsu, K.; Matsuzawa, Y. Effects of soy protein diet on the expression of adipose genes and plasma adiponectin Horm. Metab. Res. 2002, 34 (11-12) 635-639
34. Nagasawa, A.; Fukui, K.; Kojima, M.; Kishida, K.; Maeda, N.; Nagaretani, H.; Hibuse, T.; Nishizawa, H.; Kihara, S.; Waki, M.; Takamatsu, K.; Funahashi, T.; Matsuzawa, Y. Divergent effects of soy protein diet on the expression of adipocytokines Biochem. Biophys. Res. Commun. 2003, 311 (4) 909-914
35. Fredenrich, A.; Grimaldi, P. A. PPAR delta: an uncompletely known nuclear receptor Diabetes Metab. 2005, 31 (1) 23-27
36. Gudbrandsen, O. A.; Wergedahl, H.; Liaset, B.; Espe, M.; Berge, R. K. Dietary proteins with high isoflavone content or low methionine-glycine and lysine-arginine ratios are hypocholesterolaemic and lower the plasma homocysteine level in male Zucker fa/fa rats Br. J. Nutr. 2005, 94 (3) 321-330
37. Slavin, J. L. Dietary fiber and body weight Nutrition 2005, 21 (3) 411-418
38. Cederroth, C. R.; Vinciguerra, M.; Gjinovci, A.; Kuhne, F.; Klein, M.; Cederroth, M.; Caille, D.; Suter, M.; Neumann, D.; James, R. W.; Doerge, D. R.; Wallimann, T.; Meda, P.; Foti, M.; Rohner-Jeanrenaud, F.; Vassalli, J. D.; Nef, S. Dietary phytoestrogens activate AMP-activated protein kinase with improvement in lipid and glucose metabolism Diabetes 2008, 57 (5) 1176-1185
39. Rasbach, K. A.; Schnellmann, R. G. Isoflavones promote mitochondrial biogenesis J. Pharmacol. Exp. Ther. 2008, 325 (2) 536-543
40. Lo, G. S.; Goldberg, A. P.; Lim, A.; Grundhauser, J. J.; Anderson, C.; Schonfeld, G. Soy Fiber Improves Lipid and Carbohydrate-Metabolism in Primary Hyperlipidemic Subjects Atherosclerosis 1986, 62 (3) 239-248
41. Martin, S. S.; Qasim, A.; Reilly, M. P. Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease J. Am. Coll. Cardiol. 2008, 52 (15) 1201-1210
42. Kern, P. A.; Di Gregorio, G. B.; Lu, T.; Rassouli, N.; Ranganathan, G. Adiponectin expression from human adipose tissue-Relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression Diabetes 2003, 52 (7) 1779-1785
43. Batterham, R. L.; Heffron, H.; Kapoor, S.; Chivers, J. E.; Chandarana, K.; Herzog, H.; Le Roux, C. W.; Thomas, E. L.; Bell, J. D.; Withers, D. J. Critical role for peptide YY in protein-mediated satiation and body-weight regulation Cell Metab. 2006, 4 (3) 223-233
44. Jang, E. H.; Moon, J. S.; Ko, J. H.; Ahn, C. W.; Lee, H. H.; Shin, J. K.; Park, C. S.; Kang, J. H. Novel black soy peptides with antiobesity effects: activation of leptin-like signaling and AMP-activated protein kinase Int. J. Obes. 2008, 32 (7) 1161-1170
45. Anderson, G. H.; Moore, S. E. Dietary proteins in the regulation of food intake and body weight in humans J. Nutr. 2004, 134 (4) 974S-979S
46. Boss, O.; Muzzin, P.; Giacobino, J. P. The uncoupling proteins, a review Eur. J. Endocrinol. 1998, 139 (1) 1-9
47. Tanaka, T.; Yamamoto, J.; Iwasaki, S.; Asaba, H.; Hamura, H.; Ikeda, Y.; Watanabe, M.; Magoori, K.; Ioka, R. X.; Tachibana, K.; Watanabe, Y.; Uchiyama, Y.; Sumi, K.; Iguchi, H.; Ito, S.; Doi, T.; Hamakubo, T.; Naito, M.; Auwerx, J.; Yanagisawa, M.; Kodama, T.; Sakai, J. Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome Proc. Natl. Acad. Sci. U.S.A. 2003, 100 (26) 15924-15929
48. Ronnett, G. V.; Kim, E. K.; Landree, L. E.; Tu, Y. J. Fatty acid metabolism as a target for obesity treatment Physiol. Behav. 2005, 85 (1) 25-35
49. Wakil, S. J. Fatty-Acid Synthase, a Proficient Multifunctional Enzyme Biochemistry 1989, 28 (11) 4523-4530
50. Yen, C. L.; Stone, S. J.; Koliwad, S.; Harris, C.; Farese, R. V., Jr. Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis J. Lipid Res. 2008, 49 (11) 2283-2301
51. Zechner, R.; Kienesberger, P. C.; Haemmerle, G.; Zimmermann, R.; Lass, A. Adipose triglyceride lipase and the lipolytic catabolism of cellular fat stores J. Lipid Res. 2009, 50 (1) 3-21
52. Zoete, V.; Grosdidier, A.; Michielin, O. Peroxisome proliferator- activated receptor structures: ligand specificity, molecular switch and interactions with regulators Biochim. Biophys. Acta 2007, 1771 (8) 915-925
53. Krey, G.; Braissant, O.; LHorset, F.; Kalkhoven, E.; Perroud, M.; Parker, M. G.; Wahli, W. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay Mol. Endocrinol. 1997, 11 (6) 779-791
54. Ye, F.; Zhang, Z. S.; Luo, H. B.; Shen, J. H.; Chen, K. X.; Shen, X.; Jiang, H. L. The dipeptide H-Trp-Glu-OH shows highly antagonistic activity against PPARgamma: bioassay with molecular modeling simulation ChemBioChem 2006, 7 (1) 74-82
55. Rowe, G. C.; Jiang, A.; Arany, Z. PGC-1 coactivators in cardiac development and disease Circ. Res. 2010, 107 (7) 825-838
56. Canto, C.; Auwerx, J. PGC-1 alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure Curr. Opin. Lipidol. 2009, 20 (2) 98-105
57. Liang, H.; Ward, W. F. PGC-1alpha: a key regulator of energy metabolism Adv. Physiol. Educ. 2006, 30 (4) 145-151
58. Hondares, E.; Pineda-Torra, I.; Iglesias, R.; Staels, B.; Villarroya, F.; Giralt, M. PPARdelta, but not PPARalpha, activates PGC-1alpha gene transcription in muscle Biochem. Biophys. Res. Commun. 2007, 354 (4) 1021-1027
59. Schwenk, R. W.; Holloway, G. P.; Luiken, J. J.; Bonen, A.; Glatz, J. F. Fatty acid transport across the cell membrane: regulation by fatty acid transporters Prostaglandins, Leukotrienes Essent. Fatty Acids 2010, 82 (4-6) 149-154
60. Hall, A. M.; Smith, A. J.; Bernlohr, D. A. Characterization of the Acyl-CoA synthetase activity of purified murine fatty acid transport protein 1 J. Biol. Chem. 2003, 278 (44) 43008-43013